Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Surgery. 2014 Jun 2;156(3):548–555. doi: 10.1016/j.surg.2014.04.014

Figure 3. Exosomal delivery of CCN2-GFP to Day 2 mouse HSC.

Figure 3

PKH26 fluorescence and CCN2, GFP or α-SMA immunofluorescence in Day 2 HSC receiving no exosomes, exosomes from control activated HSC, or exosomes from CCN2-GFP-transfected activated HSC.

HHS Vulnerability Disclosure